CGON

CG ONCOLOGY INC

CGON·156944100·US·Common Stock·Healthcare - Biotechnology-Activist

CGON (CG ONCOLOGY INC) is held by 126 institutional investors as of Q1 2026. Largest holders: RTW INVESTMENTS, LP ($472.7M), WELLINGTON MANAGEMENT GROUP LLP ($363.5M), BlackRock, Inc. ($342.7M). Net institutional sentiment: Mixed.

126
Holders
Avg rating(24 Elite)
$3.9B
Total Value
66% (131)
Fund Consensus
84 buying - 43 selling
CGONSmart Money Verdict
View all
Held by 126 funds
24 elite
Who's Trading
InsiderMJMulay JamesSell $1.8MJul 10, 2026
ActivistTRT. Rowe Price Investment Management, Inc.8.0%May 15, 2026
ActivistRTW Investments, LPRTW Investments, LP8.3%May 15, 2026
InsiderMJMulay JamesSell $1.1MApr 17, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 26, 2026
InsiderMJMulay JamesSell $83KMar 16, 2026
InsiderMJMulay JamesSell $42KMar 16, 2026
InsiderMJMulay JamesSell $556KJan 9, 2026
InsiderMJMulay JamesSell $29KJan 9, 2026
InsiderPEPOST LEONARD ESell $41KNov 17, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
7M(+247.1%)$472.7M4.7%+41.54%
93
Decreased
5.4M(-10.5%)$363.5M0.1%+105.34%
0
Increased
5.1M(+4.6%)$342.7M0.0%+145.96%
32
Decreased
3.8M(-12.4%)$254.8M0.0%+160.66%
0
Increased
3.7M(+6.1%)$247.2M0.0%+99.84%
33
New
3.1M$209.5M0.0%+24.26%
42
New
3M$205.3M0.0%+24.26%
42
Decreased
2.6M(-11.7%)$179.2M0.0%+106.43%
0
Increased
1.6M(+5.7%)$108.1M0.0%+91.90%
32
Decreased
1.5M(-3.5%)$102M0.0%+96.61%
0
Increased
1.4M(+21.8%)$98.1M0.0%+105.29%
36
Decreased
1.3M(-31.8%)$88.8M0.0%+173.33%
0
Decreased
1.2M(-12.5%)$78.5M0.0%+158.48%
0
Decreased
1.1M(-2.4%)$72.1M0.0%+147.97%
0
New
999,623$67.7M0.5%+24.26%
49
Decreased
1.3M(-20.0%)$53.6M0.0%+112.94%
0
Increased
730,283(+3.6%)$49.4M0.0%+88.29%
30
Decreased
704,461(-35.9%)$47.7M0.2%+92.37%
0
Increased
674,000(+8325.0%)$45.6M0.3%+25.11%
56
Decreased
542,378(-0.1%)$36.7M0.0%+95.01%
0

Showing 1-20 of 131

1 / 7

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used